A relapsed aggressive NK-cell leukemia with CNS involvement diagnosed by cerebrospinal fluid examination

Diagn Cytopathol. 2016 Apr;44(4):314-6. doi: 10.1002/dc.23454. Epub 2016 Feb 18.

Authors

Zhaodong Xu^{1

2}, Luke Shier^{1

2}, Lothar Huebsch³

Affiliations

¹ Division of Haematopathology and Transfusion Medicine, Department of Pathology and Laboratory Medicine, the Ottawa Hospital and Eastern Ontario Regional Laboratory Association, Ottawa, Canada.
² Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, K1H 8L6, Canada.
³ Division of Haematology, Department of Medicine, the Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada.

PMID: 26890009
DOI: 10.1002/dc.23454

No abstract available

Keywords: CSF; aggressive NK-cell leukemia.

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / therapeutic use
Central Nervous System Neoplasms / cerebrospinal fluid
Central Nervous System Neoplasms / diagnosis*
Central Nervous System Neoplasms / drug therapy
Central Nervous System Neoplasms / pathology
Epstein-Barr Virus Infections / cerebrospinal fluid
Epstein-Barr Virus Infections / diagnosis*
Epstein-Barr Virus Infections / drug therapy
Epstein-Barr Virus Infections / pathology
Fatal Outcome
Herpesvirus 4, Human / pathogenicity
Herpesvirus 4, Human / physiology
Humans
Killer Cells, Natural / drug effects
Killer Cells, Natural / metabolism
Killer Cells, Natural / pathology*
Leukemia, Prolymphocytic, T-Cell / cerebrospinal fluid
Leukemia, Prolymphocytic, T-Cell / diagnosis*
Leukemia, Prolymphocytic, T-Cell / drug therapy
Leukemia, Prolymphocytic, T-Cell / pathology
Magnetic Resonance Imaging
Male
Middle Aged
Recurrence
Spine / drug effects
Spine / innervation
Spine / pathology
T-Lymphocytes / drug effects
T-Lymphocytes / metabolism
T-Lymphocytes / pathology

Substances

Antineoplastic Agents